GEMZAR 1 G (Gemcitabine Injection 1 g): Complete Product Profile, Uses, Dosage, Safety, Storage & Patient Information GEMZAR 1 G contains Gemcitabine 1 g for Injection, a prescription anticancer medicine used in the treatment of several types of cancer under the supervision of an oncologist. It belongs to the antimetabolite chemotherapy class and is administered in hospitals or specialized cancer treatment centers by trained healthcare professionals. This guide provides detailed information about GEMZAR 1 G, including its approved therapeutic uses, mechanism of action, dosage guidance, safety considerations, storage recommendations, and regulatory information. It is intended for educational purposes and should not replace advice from a qualified healthcare provider. What is GEMZAR 1 G? GEMZAR 1 G contains Gemcitabine, a cytotoxic chemotherapy medicine that interferes with DNA synthesis in rapidly dividing cancer cells. This helps slow or stop the growth of cancer cells. The medicine is supplied as: Brand Name: GEMZAR 1 G Generic Name: Gemcitabine for Injection Strength: 1 g Pack Size: 1 Vial Dosage Form: Sterile Injection Route: Intravenous Infusion Prescription Status: Prescription Only Medicine Important correction: GEMZAR (Gemcitabine) is not an anti-HIV medicine. It is an anticancer chemotherapy medication used for the treatment of specific cancers. GEMZAR 1 G may be prescribed as part of cancer treatment protocols for: Non-Small Cell Lung Cancer (NSCLC) Gemcitabine may be used alone or in combination with other chemotherapy medicines for selected patients with advanced or metastatic non-small cell lung cancer. Pancreatic Cancer Gemcitabine has been widely used in the treatment of locally advanced or metastatic pancreatic cancer and may help improve disease control in eligible patients. Breast Cancer In combination with other chemotherapy medicines, Gemcitabine may be prescribed for advanced or metastatic breast cancer when clinically appropriate. Ovarian Cancer Gemcitabine may be recommended in combination treatment for recurrent ovarian cancer based on clinical assessment. Bladder Cancer Gemcitabine is also used in certain treatment regimens for advanced bladder cancer. How GEMZAR Helps Treatment goals may include: Slowing cancer cell growth Helping reduce tumor progression Supporting disease management Improving treatment response when combined with other therapies Assisting oncologists in individualized cancer treatment plans How GEMZAR Works Gemcitabine belongs to the antimetabolite group of chemotherapy medicines. After administration: The medicine enters rapidly dividing cancer cells. It is converted into active metabolites inside the cell. These metabolites interfere with DNA synthesis. Cancer cells are unable to complete replication. Cell division stops. Damaged cancer cells undergo programmed cell death. Because chemotherapy also affects some healthy rapidly dividing cells, side effects can occur and require medical monitoring. Is GEMZAR 1 G a chemotherapy medicine? Yes. Gemcitabine is a prescription chemotherapy medicine used to treat certain cancers. Is GEMZAR 1 G an antibiotic? No. Can patients administer it at home? No. It should be administered by trained healthcare professionals. Does treatment require blood tests? Yes. Regular monitoring is generally required during therapy. Why Choose Primecare Impex Primecare Impex focuses on supplying pharmaceutical products with attention to product quality, documentation, and customer support. Contact Primecare Impex Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp: https://wa.me/919673008130 Doctors commonly monitor: Complete Blood Count (CBC) Liver Function Tests Kidney Function Tests Body weight Vital signs Treatment response Signs of infection Overall tolerance Common Side Effects Fatigue Fever Nausea Vomiting Reduced appetite Hair thinning Skin rash Mild swelling Flu-like symptoms Blood-Related Effects Routine blood tests are essential because Gemcitabine may reduce: White blood cells Red blood cells Platelets Low blood counts can increase the risk of infection, anemia, or bleeding. Liver Monitoring Healthcare providers may monitor: Liver enzymes Bilirubin Liver function tests Kidney Monitoring Kidney function should be assessed before and during treatment. Lung Monitoring Rare but serious pulmonary complications have been reported. Patients should promptly report: Persistent cough Difficulty breathing Chest discomfort Allergic Reactions Seek immediate medical attention if symptoms such as: Swelling Difficulty breathing Severe rash Dizziness occur after administration. Pregnancy and Breastfeeding Gemcitabine may harm an unborn baby. Patients should discuss: Pregnancy Family planning Breastfeeding with their healthcare provider before treatment.